Deep rTMS of the insula and prefrontal cortex in smokers with schizophrenia: Proof-of-concept study.


Journal

Schizophrenia (Heidelberg, Germany)
ISSN: 2754-6993
Titre abrégé: Schizophrenia (Heidelb)
Pays: Germany
ID NLM: 9918367987006676

Informations de publication

Date de publication:
25 02 2022
Historique:
received: 26 08 2021
accepted: 17 12 2021
entrez: 26 2 2022
pubmed: 27 2 2022
medline: 27 2 2022
Statut: epublish

Résumé

Patients with schizophrenia have a high prevalence of cigarette smoking and respond poorly to conventional treatments, highlighting the need for new therapies. We conducted a mechanistic, proof-of-concept study using bilateral deep repetitive transcranial magnetic stimulation (dTMS) of insular and prefrontal cortices at high frequency, using the specialized H4 coil. Feasibility of dTMS was tested for disruption of tobacco self-administration, insula target engagement, and insula circuit modulation, all of which were a priori outcomes of interest. Twenty patients completed the study, consisting of weekday dTMS sessions (randomization to active dTMS or sham; double-blind; 10 patients per group), a laboratory tobacco self-administration paradigm (pre/post assessments), and multimodal imaging (three MRI total sessions). Results showed that participants assigned to active dTMS were slower to initiate smoking their first cigarette compared with sham, consistent with smoking disruption. The imaging analyses did not reveal significant Time × Group interactions, but effects were in the anticipated directions. In arterial spin labeling analyses testing for target engagement, an overall decrease in insula blood flow, measured during a post-treatment MRI versus baseline, was numerically more pronounced in the active dTMS group than sham. In fMRI analyses, resting-state connectivity between the insula and default mode network showed a numerically greater change from baseline in the active dTMS group than sham, consistent with a functional change to insula circuits. Exploratory analyses further suggested a therapeutic effect of dTMS on symptoms of psychosis. These initial observations pave the way for future confirmatory studies of dTMS in smoking patients with schizophrenia.

Identifiants

pubmed: 35217662
doi: 10.1038/s41537-022-00224-0
pii: 10.1038/s41537-022-00224-0
pmc: PMC8881463
doi:

Types de publication

Journal Article

Langues

eng

Pagination

6

Subventions

Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
ID : F30MH122136
Organisme : U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA)
ID : K01DA037452
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
ID : K01MH107763
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
ID : K23MH115291
Organisme : NIGMS NIH HHS
ID : T32 GM008444
Pays : United States
Organisme : U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA)
ID : R21DA041128
Organisme : NIMH NIH HHS
ID : K23 MH115291
Pays : United States
Organisme : NIDA NIH HHS
ID : K01 DA037452
Pays : United States
Organisme : NIDA NIH HHS
ID : R21 DA041128
Pays : United States
Organisme : U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA)
ID : R21DA051179
Organisme : NIMH NIH HHS
ID : F30 MH122136
Pays : United States
Organisme : NIDA NIH HHS
ID : R21 DA051179
Pays : United States
Organisme : NIMH NIH HHS
ID : K01 MH107763
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

George, T. P. & Ziedonis, D. M. Addressing tobacco dependence in psychiatric practice: Promises and pitfalls. Can. J. Psychiatry 54, 353–355 (2009).
pubmed: 19527555 doi: 10.1177/070674370905400602
Ziedonis, D. et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tobacco Res.: Off. J. Soc. Res. Nicotine Tobacco 10, 1691–1715 (2008).
doi: 10.1080/14622200802443569
de Leon, J. & Diaz, F. J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizopr. Res. 76, 135–157 (2005).
doi: 10.1016/j.schres.2005.02.010
Lucatch, A. M., Lowe, D. J. E., Clark, R. C., Kozak, K. & George, T. P. Neurobiological determinants of tobacco smoking in schizophrenia. Front. Psychiatry/Front. Res. Found. 9, 672 (2018).
Cather, C., Pachas, G. N., Cieslak, K. M. & Evins, A. E. Achieving smoking cessation in individuals with schizophrenia: Special considerations. CNS Drugs 31, 471–481 (2017).
pubmed: 28550660 pmcid: 5646360 doi: 10.1007/s40263-017-0438-8
Pearsall, R., Smith, D. J. & Geddes, J. R. Pharmacological and behavioural interventions to promote smoking cessation in adults with schizophrenia and bipolar disorders: a systematic review and meta-analysis of randomised trials. BMJ Open 9, e027389 (2019).
pubmed: 31784428 pmcid: 6924825 doi: 10.1136/bmjopen-2018-027389
Chawla, M. & Garrison, K. A. Neurobiological considerations for tobacco use disorder. Curr. Behav. Neurosci. Rep. 5, 238–248 (2018).
pubmed: 31106112 pmcid: 6519951 doi: 10.1007/s40473-018-0168-3
Paulus, M. P. & Stewart, J. L. Interoception and drug addiction. Neuropharmacology 76 Pt B, 342–350 (2014).
pubmed: 23855999 doi: 10.1016/j.neuropharm.2013.07.002
Droutman, V., Read, S. J. & Bechara, A. Revisiting the role of the insula in addiction. Trends Cogn. Sci. 19, 414–420 (2015).
pubmed: 26066588 pmcid: 4486609 doi: 10.1016/j.tics.2015.05.005
Naqvi, N. H., Gaznick, N., Tranel, D. & Bechara, A. The insula: A critical neural substrate for craving and drug seeking under conflict and risk. Ann. NY Acad. Sci. 1316, 53–70 (2014).
pubmed: 24690001 doi: 10.1111/nyas.12415
Abdolahi, A. et al. Immediate and sustained decrease in smoking urges after acute insular cortex damage. Nicotine Tobacco Res.: Off. J. Soc. Res. Nicotine Tobacco 19, 756–762 (2017).
doi: 10.1093/ntr/ntx046
Naqvi, N. H., Rudrauf, D., Damasio, H. & Bechara, A. Damage to the insula disrupts addiction to cigarette smoking. Science 315, 531–534 (2007).
pubmed: 17255515 pmcid: 3698854 doi: 10.1126/science.1135926
Tanabe, J., Regner, M., Sakai, J., Martinez, D. & Gowin, J. Neuroimaging reward, craving, learning, and cognitive control in substance use disorders: Review and implications for treatment. Br. J. Radiol. 92, 20180942 (2019).
pubmed: 30855982 pmcid: 6732921 doi: 10.1259/bjr.20180942
Jasinska, A. J., Stein, E. A., Kaiser, J., Naumer, M. J. & Yalachkov, Y. Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies. Neurosci. Biobehav. Rev. 38, 1–16 (2014).
pubmed: 24211373 doi: 10.1016/j.neubiorev.2013.10.013
Luijten, M. et al. Neurobiological substrate of smoking-related attentional bias. Neuroimage 54, 2374–2381 (2011).
pubmed: 20932921 doi: 10.1016/j.neuroimage.2010.09.064
Claus, E. D., Blaine, S. K., Filbey, F. M., Mayer, A. R. & Hutchison, K. E. Association between nicotine dependence severity, BOLD response to smoking cues, and functional connectivity. Neuropsychopharmacology 38, 2363–2372 (2013).
pubmed: 23708507 pmcid: 3799055 doi: 10.1038/npp.2013.134
Janes, A. C. et al. Revisiting the role of the insula and smoking cue-reactivity in relapse: A replication and extension of neuroimaging findings. Drug Alcohol. Depend 179, 8–12 (2017).
pubmed: 28735078 pmcid: 5599349 doi: 10.1016/j.drugalcdep.2017.06.012
Namkung, H., Kim, S. H. & Sawa, A. The insula: An underestimated brain area in clinical neuroscience, psychiatry, and neurology. Trends Neurosci. 40, 200–207 (2017).
pubmed: 28314446 pmcid: 5538352 doi: 10.1016/j.tins.2017.02.002
Craig, A. D. How do you feel—now? The anterior insula and human awareness. Nat. Rev. Neurosci. 10, 59–70 (2009).
pubmed: 19096369 doi: 10.1038/nrn2555
Fedota, J. R. et al. Nicotine abstinence influences the calculation of salience in discrete insular circuits. Biol. Psychiatry Cogn. Neurosci. Neuroimag. 3, 150–159 (2018).
Moran-Santa Maria, M. M. et al. Right anterior insula connectivity is important for cue-induced craving in nicotine-dependent smokers. Addict. Biol. 20, 407–414 (2015).
pubmed: 24529072 doi: 10.1111/adb.12124
Janes, A. C., Krantz, N. L., Nickerson, L. D., Frederick, B. B. & Lukas, S. E. Craving and cue reactivity in nicotine-dependent tobacco smokers is associated with different insula networks. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 5, 76–83 (2020).
pubmed: 31706906
Janes, A. C., Farmer, S., Peechatka, A. L., Frederick Bde, B. & Lukas, S. E. Insula-dorsal anterior cingulate cortex coupling is associated with enhanced brain reactivity to smoking cues. Neuropsychopharmacology 40, 1561–1568 (2015).
pubmed: 25567427 pmcid: 4915269 doi: 10.1038/npp.2015.9
Moran, L. V. et al. Disruption of anterior insula modulation of large-scale brain networks in schizophrenia. Biol. Psychiatry 74, 467–474 (2013).
pubmed: 23623456 pmcid: 3735654 doi: 10.1016/j.biopsych.2013.02.029
Shepherd, A. M., Matheson, S. L., Laurens, K. R., Carr, V. J. & Green, M. J. Systematic meta-analysis of insula volume in schizophrenia. Biol. Psychiatry 72, 775–784 (2012).
pubmed: 22621997 doi: 10.1016/j.biopsych.2012.04.020
Jorgensen, K. N. et al. Cigarette smoking is associated with thinner cingulate and insular cortices in patients with severe mental illness. J. Psychiatry Neurosci.: JPN 40, 241–249 (2015).
pubmed: 25672482 pmcid: 4478057 doi: 10.1503/jpn.140163
Moran, L. V., Sampath, H., Stein, E. A. & Hong, L. E. Insular and anterior cingulate circuits in smokers with schizophrenia. Schizophr. Res. 142, 223–229 (2012).
pubmed: 23021898 pmcid: 3502674 doi: 10.1016/j.schres.2012.08.033
Sutherland, M. T. et al. Down-regulation of amygdala and insula functional circuits by varenicline and nicotine in abstinent cigarette smokers. Biol. Psychiatry 74, 538–546 (2013).
pubmed: 23506999 pmcid: 3775982 doi: 10.1016/j.biopsych.2013.01.035
Ibrahim, C. et al. The insula: A brain stimulation target for the treatment of addiction. Front. Pharmacol. 10, 720 (2019).
pubmed: 31312138 pmcid: 6614510 doi: 10.3389/fphar.2019.00720
Regner, M. F. et al. The insula in nicotine use disorder: Functional neuroimaging and implications for neuromodulation. Neurosci. Biobehav. Rev. 103, 414–424 (2019).
pubmed: 31207255 doi: 10.1016/j.neubiorev.2019.06.002
Zhang, J. J. Q., Fong, K. N. K., Ouyang, R. G., Siu, A. M. H. & Kranz, G. S. Effects of repetitive transcranial magnetic stimulation (rTMS) on craving and substance consumption in patients with substance dependence: a systematic review and meta-analysis. Addiction 114, 2137–2149 (2019).
pubmed: 31328353 doi: 10.1111/add.14753
Zangen, A., Roth, Y., Voller, B. & Hallett, M. Transcranial magnetic stimulation of deep brain regions: Evidence for efficacy of the H-coil. Clin. Neurophysiol. 116, 775–779 (2005).
pubmed: 15792886 doi: 10.1016/j.clinph.2004.11.008
Dinur-Klein, L. et al. Smoking cessation induced by deep repetitive transcranial magnetic stimulation of the prefrontal and insular cortices: a prospective, randomized controlled trial. Biol. Psychiatry 76, 742–749 (2014).
pubmed: 25038985 doi: 10.1016/j.biopsych.2014.05.020
Zangen, A. et al. Repetitive transcranial magnetic stimulation for smoking cessation: A pivotal multicenter double-blind randomized controlled trial. World Psychiatry: Off. J. World Psychiatric Assoc. (WPA) 20, 397–404 (2021).
doi: 10.1002/wps.20905
Hauer, L. et al. Effects of repetitive transcranial magnetic stimulation on nicotine consumption and craving: A systematic review. Psychiatry Res. 281, 112562 (2019).
pubmed: 31521838 doi: 10.1016/j.psychres.2019.112562
Lee, M. R. et al. Repetitive transcranial magnetic stimulation delivered with an H-coil to the right insula reduces functional connectivity between insula and medial prefrontal cortex. Neuromodul.: J. Int. Neuromodul. Soc. 23, 384–392 (2020).
doi: 10.1111/ner.13033
Kay, S. R., Fiszbein, A. & Opler, L. A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13, 261–276 (1987).
pubmed: 3616518 doi: 10.1093/schbul/13.2.261
First, M. B., Williams, J. B. W., Karg, R. S. & Spitzer, R. L. Structured Clinical Interview for DSM-5—Research Version (SCID-5 for DSM-5, Research Version; SCID-5-RV) (American Psychiatric Association, 2015).
McKee, S. A., Weinberger, A. H., Shi, J., Tetrault, J. & Coppola, S. Developing and validating a human laboratory model to screen medications for smoking cessation. Nicotine Tobacco Res.: Off. J. Soc. Res. Nicotine Tobacco 14, 1362–1371 (2012).
doi: 10.1093/ntr/nts090
Mann-Wrobel, M. C., Bennett, M. E., Weiner, E. E., Buchanan, R. W. & Ball, M. P. Smoking history and motivation to quit in smokers with schizophrenia in a smoking cessation program. Schizophr. Res. 126, 277–283 (2011).
pubmed: 21112185 doi: 10.1016/j.schres.2010.10.030
Wang, Z. et al. Neural substrates of abstinence-induced cigarette cravings in chronic smokers. J. Neurosci. 27, 14035–14040 (2007).
pubmed: 18094242 pmcid: 2153440 doi: 10.1523/JNEUROSCI.2966-07.2007
Borckardt, J. J. et al. The painfulness of active, but not sham, transcranial magnetic stimulation decreases rapidly over time: results from the double-blind phase of the OPT-TMS Trial. Brain Stimul. 6, 925–928 (2013).
pubmed: 23769413 doi: 10.1016/j.brs.2013.04.009
Spagnolo, P. A. et al. Lack of target engagement following low-frequency deep transcranial magnetic stimulation of the anterior insula. Neuromodul.: J. Int. Neuromodul. Soc. 22, 877–883 (2019).
doi: 10.1111/ner.12875
Kindler, J. et al. Reduced neuronal activity in language-related regions after transcranial magnetic stimulation therapy for auditory verbal hallucinations. Biol. Psychiatry 73, 518–524 (2013).
pubmed: 22840762 doi: 10.1016/j.biopsych.2012.06.019
Power, J. D. et al. Functional network organization of the human brain. Neuron 72, 665–678 (2011).
pubmed: 22099467 pmcid: 3222858 doi: 10.1016/j.neuron.2011.09.006
Sheffield, J. M. & Barch, D. M. Cognition and resting-state functional connectivity in schizophrenia. Neurosci. Biobehav. Rev. 61, 108–120 (2016).
pubmed: 26698018 doi: 10.1016/j.neubiorev.2015.12.007
Sutherland, M. T., Carroll, A. J., Salmeron, B. J., Ross, T. J. & Stein, E. A. Insula’s functional connectivity with ventromedial prefrontal cortex mediates the impact of trait alexithymia on state tobacco craving. Psychopharmacology 228, 143–155 (2013).
pubmed: 23455594 doi: 10.1007/s00213-013-3018-8
Dong, D., Wang, Y., Chang, X., Luo, C. & Yao, D. Dysfunction of large-scale brain networks in schizophrenia: A meta-analysis of resting-state functional connectivity. Schizophr. Bull. 44, 168–181 (2018).
pubmed: 28338943 doi: 10.1093/schbul/sbx034
Tian, Y., Zalesky, A., Bousman, C., Everall, I. & Pantelis, C. Insula functional connectivity in schizophrenia: Subregions, gradients, and symptoms. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 4, 399–408 (2019).
pubmed: 30691966
Peters, H. et al. Changes in extra-striatal functional connectivity in patients with schizophrenia in a psychotic episode. Br. J. Psychiatry 210, 75–82 (2017).
pubmed: 26892851 doi: 10.1192/bjp.bp.114.151928
Limongi, R. et al. Glutamate and dysconnection in the salience network: Neurochemical, effective connectivity, and computational evidence in schizophrenia. Biol. Psychiatry 88, 273–281 (2020).
pubmed: 32312577 doi: 10.1016/j.biopsych.2020.01.021
Duan, X. et al. Effect of risperidone monotherapy on dynamic functional connectivity of insular subdivisions in treatment-naive, first-episode schizophrenia. Schizophr. Bull. 46, 650–660 (2020).
pubmed: 31504959 doi: 10.1093/schbul/sbz087
Cauda, F. et al. Functional connectivity of the insula in the resting brain. Neuroimage 55, 8–23 (2011).
pubmed: 21111053 doi: 10.1016/j.neuroimage.2010.11.049
Hanlon, C. A., Dowdle, L. T. & Henderson, J. S. Modulating neural circuits with transcranial magnetic stimulation: Implications for addiction treatment development. Pharmacol. Rev. 70, 661–683 (2018).
pubmed: 29945899 pmcid: 6020107 doi: 10.1124/pr.116.013649
Appelbaum, P. S. & Grisso, T. MacArthur Competence Assessment Tool for Clinical Research (MacCat-CR) (Professional Resource Press/Professional Resource Exchange, 2001).
Pocock, S. J. & Simon, R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31, 103–115 (1975).
pubmed: 1100130 doi: 10.2307/2529712
Wang, Z. et al. Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx. Magn. Reson. Imaging 26, 261–269 (2008).
pubmed: 17826940 doi: 10.1016/j.mri.2007.07.003
Buxton, R. B. et al. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn. Reson. Med. 40, 383–396 (1998).
pubmed: 9727941 doi: 10.1002/mrm.1910400308
He, X., Wengler, K. & Schweitzer, M. E. Diffusion sensitivity of 3D-GRASE in arterial spin labeling perfusion. Magn. Reson. Med. 80, 736–747 (2018).
pubmed: 29315770 doi: 10.1002/mrm.27058
Fischl, B. FreeSurfer. Neuroimage 62, 774–781 (2012).
pubmed: 22248573 doi: 10.1016/j.neuroimage.2012.01.021
Moeller, S. et al. Multiband multislice GE-EPI at 7 Tesla, with 16-fold acceleration using partial parallel imaging with application to high spatial and temporal whole-brain fMRI. Magn. Reson. Med. 63, 1144–1153 (2010).
pubmed: 20432285 pmcid: 2906244 doi: 10.1002/mrm.22361
Van Essen, D. C. et al. The WU-Minn human connectome project: An overview. Neuroimage 80, 62–79 (2013).
pubmed: 23684880 doi: 10.1016/j.neuroimage.2013.05.041
Gordon, E. M. et al. Generation and evaluation of a cortical area parcellation from resting-state correlations. Cereb. Cortex 26, 288–303 (2016).
pubmed: 25316338 doi: 10.1093/cercor/bhu239
Desikan, R. S. et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31, 968–980 (2006).
pubmed: 16530430 doi: 10.1016/j.neuroimage.2006.01.021
Fischl, B. et al. Automatically parcellating the human cerebral cortex. Cereb. Cortex 14, 11–22 (2004).
pubmed: 14654453 doi: 10.1093/cercor/bhg087
Hollingshead, A. B. Four-factor index of social status. Unpublished paper (1975).

Auteurs

Scott J Moeller (SJ)

Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA. scott.moeller@stonybrookmedicine.edu.

Roberto Gil (R)

Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.

Jodi J Weinstein (JJ)

Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.

Topaz Baumvoll (T)

Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.

Kenneth Wengler (K)

Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.
Columbia University, New York State Psychiatric Institute, New York, NY, 10032, USA.

Natalka Fallon (N)

Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.

Jared X Van Snellenberg (JX)

Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.

Sameera Abeykoon (S)

Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.

Greg Perlman (G)

Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.

John Williams (J)

Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.

Lucian Manu (L)

Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.

Mark Slifstein (M)

Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.

Clifford M Cassidy (CM)

University of Ottawa Institute of Mental Health Research, affiliated with The Royal, Ottawa, ON, K1Z 8N3, Canada.

Diana M Martinez (DM)

Columbia University, New York State Psychiatric Institute, New York, NY, 10032, USA.

Anissa Abi-Dargham (A)

Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA. anissa.abi-dargham@stonybrookmedicine.edu.

Classifications MeSH